JPH0140808B2 - - Google Patents

Info

Publication number
JPH0140808B2
JPH0140808B2 JP55073653A JP7365380A JPH0140808B2 JP H0140808 B2 JPH0140808 B2 JP H0140808B2 JP 55073653 A JP55073653 A JP 55073653A JP 7365380 A JP7365380 A JP 7365380A JP H0140808 B2 JPH0140808 B2 JP H0140808B2
Authority
JP
Japan
Prior art keywords
oral liquid
esters
polyethylene glycol
methoxsalen
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55073653A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5659705A (en
Inventor
Etsuchi Shuraagaa Rudoihi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEROTSUTO PHARM GmbH
Original Assignee
GEROTSUTO PHARM GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEROTSUTO PHARM GmbH filed Critical GEROTSUTO PHARM GmbH
Publication of JPS5659705A publication Critical patent/JPS5659705A/ja
Publication of JPH0140808B2 publication Critical patent/JPH0140808B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP7365380A 1979-06-25 1980-05-31 88methoxyyfuroo*3**2* 6*7**coumarin medicine Granted JPS5659705A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT444979A AT361116B (de) 1979-06-25 1979-06-25 Verfahren zur herstellung einer pharma- zeutischen zubereitung zur oralen verabreichung

Publications (2)

Publication Number Publication Date
JPS5659705A JPS5659705A (en) 1981-05-23
JPH0140808B2 true JPH0140808B2 (enExample) 1989-08-31

Family

ID=3564155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7365380A Granted JPS5659705A (en) 1979-06-25 1980-05-31 88methoxyyfuroo*3**2* 6*7**coumarin medicine

Country Status (3)

Country Link
JP (1) JPS5659705A (enExample)
AT (1) AT361116B (enExample)
BE (1) BE883931A (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5335124A (en) * 1976-09-10 1978-04-01 Nippon Denso Co Ltd Converter
LU80347A1 (fr) * 1977-10-21 1979-03-16 Goupil J 5-methoxy-psoralene comme nouveau medicament et procede de synthese

Also Published As

Publication number Publication date
BE883931A (fr) 1980-10-16
ATA444979A (de) 1980-07-15
AT361116B (de) 1981-02-25
JPS5659705A (en) 1981-05-23

Similar Documents

Publication Publication Date Title
BRPI0612921A2 (pt) composições farmacêuticas de um esteróide neuroativo e métodos de uso do mesmo
JPH0245416A (ja) 分散性シメチジン錠剤及びその製造方法
RU2371176C2 (ru) Самоэмульгирующаяся система доставки лекарственного средства бутилфталида, способ ее получения и применения
Murdoch et al. Food additive-induced urticaria: studies of mediator release during provocation tests
JP4212272B2 (ja) トリグリセリド低下剤組成物
KR102542275B1 (ko) Hc-1119 제제 및 그 제조방법 및 용도
AU2021206858B2 (en) Isotretinoin formulations and uses and methods thereof
US4913901A (en) Pharmaceutical composition for oral administration and process for the use thereof
Stolk et al. Serum levels of 8‐methoxypsoralen: difference between two oral methods of administration
Sumaiyah et al. The effect of crospovidone on the dissolution profile of amlodipine besylate from fast orally dissolving film
JPH0140808B2 (enExample)
JPH01143831A (ja) 外用液剤
Singh et al. Formulation and evaluation of phytosomal gel of resveratrol
CN107296789A (zh) 一种含有枸橼酸西地那非的外用药物组合物
Shalini et al. Formulation And Evaluation Of Ketoconazole Topical Gel.
Milhorat et al. Studies in Diseases of Muscle: II. Effect of Varying Amounts of Ingested Creatine on Creatine Tolerance in Progressive Muscular Dystrophy
Brogan et al. The effect of bromhexine on sputum from patients with chronic bronchitis and asthma
Ahmed et al. Formulation and Evaluation of Fast Disintegrating Tablet of Atenolol Using Modified Okra Gum as Natural Super Disintegrant
JPH07116037B2 (ja) ビタミンｅ製剤組成物
HU200689B (en) Process for producing endermic pharmaceutical compositions comprising pyrazolo(1,5-a)pyridine derivatives as active ingredient
JP2519954B2 (ja) 診断用負荷試験剤
Plavšić et al. Pharmacokinetics of Oral Gemfibrozil in Healthy Volunteers
CN120437049A (zh) 改进配方的维生素d2注射液组合物及制备方法
Gotoff et al. Sustained-release aspirin in children
CN105213306A (zh) 一种雪上一支蒿微乳及其制作方法